Multimodal fusion in neuroimaging combines data from multiple imaging modalities to
overcome the fundamental limitations of individual modalities. Neuroimaging fusion can …

The neuroimaging has been applied in the study of pathophysiology in major depressive
disorder (MDD). In this review article, several kinds of methodologies of neuroimaging would …

Intravenous ketamine is posited to rapidly reverse depression by rapidly enhancing
neuroplasticity. In human patients, we quantified gray matter microstructural changes on a …

Objective The functional connectivity (FC) of major depression disorder (MDD) has not been
well studied under naturalistic and continuous stimuli conditions. In this study, we …

Migraine is a symptomatically heterogeneous condition, of which headache is just one
manifestation. Migraine is a disorder of altered sensory thresholding, with hypersensitivity …

Ketamine is an effective antidepressant, but there is substantial variability in patient
response and the precise mechanism of action is unclear. Neuroimaging can provide …

Ketamine offers promising new therapeutic options for difficult-to-treat depression. The
efficacy of treatment response, including ketamine, has been intricately linked to EEG …

Major depressive disorder is a highly prevalent psychiatric disorder. Despite an extensive
range of treatment options, about a third of patients still struggle to respond to available …

The neuroimaging is an important tool for understanding the biomarkers and predicting
treatment responses in major depressive disorder (MDD). The potential biomarkers and …

Depression is one of the most common mental disorders, predicted to be the leading cause
of disease burden by the next decade. There is great deal of emphasis on the central origin …